Prezista 100 mg/ml orale Suspension Uswisi - Kifaransa - Swissmedic (Swiss Agency for Therapeutic Products)

prezista 100 mg/ml orale suspension

janssen-cilag ag - darunavirum - orale suspension - darunavirum 100 mg ut darunavirum ethanolum, hydroxypropylcellulosum, cellulosum microcristallinum, carmellosum natricum, acidum citricum monohydricum, sucralosum, acidum hydrochloridum concentratum, aromatica (geschmacksüberdeckungsaroma), aromatica (erdbeer), e 219 3.43 mg, aqua purificata ad suspensionem pro 1 ml corresp. natrium 570 µg. - les infections à vih - synthetika

Metoprolol-Mepha 25 mg Depotabs Metoprolol-Mepha 25 mg Depotabs Uswisi - Kifaransa - Swissmedic (Swiss Agency for Therapeutic Products)

metoprolol-mepha 25 mg depotabs metoprolol-mepha 25 mg depotabs

mepha pharma ag - metoprololi succinas - metoprolol-mepha 25 mg depotabs - metoprololi tartras 25 mg corresp. metoprololi succinas 23.75 mg, sacchari sphaerae corresp. saccharum 1.84 mg et maydis amylum, macrogolum 6000, polyacrylatis dispersio 30 per centum, talcum, povidonum, cellulosum microcristallinum, magnesii stearas, silica colloidalis anhydrica, Überzug: hypromellosum, talcum, macrogolum 6000, e 171, pro compresso obducto. - les bêta-bloquants - synthetika

Metoprolol-Mepha 50 mg Depotabs Uswisi - Kifaransa - Swissmedic (Swiss Agency for Therapeutic Products)

metoprolol-mepha 50 mg depotabs

mepha pharma ag - metoprololi succinas - depotabs - metoprololi tartras 50 mg corresp. metoprololi succinas 47.5 mg, sacchari sphaerae corresp. saccharum 3.68 mg et maydis amylum, macrogolum 6000, polyacrylatis dispersio 30 per centum, talcum, povidonum, cellulosum microcristallinum, magnesii stearas, silica colloidalis anhydrica, Überzug: hypromellosum, talcum, macrogolum 6000, e 171, pro compresso obducto. - les bêta-bloquants - synthetika

Metoprolol-Mepha 100 mg Depotabs Uswisi - Kifaransa - Swissmedic (Swiss Agency for Therapeutic Products)

metoprolol-mepha 100 mg depotabs

mepha pharma ag - metoprololi succinas - depotabs - metoprololi tartras 100 mg corresp. metoprololi succinas 95 mg, sacchari sphaerae corresp. saccharum 7.36 mg et maydis amylum, macrogolum 6000, polyacrylatis dispersio 30 per centum, talcum, povidonum, cellulosum microcristallinum, magnesii stearas, silica colloidalis anhydrica, Überzug: hypromellosum, talcum, macrogolum 6000, e 171, pro compresso obducto. - les bêta-bloquants - synthetika

Metoprolol-Mepha 200 mg Depotabs Uswisi - Kifaransa - Swissmedic (Swiss Agency for Therapeutic Products)

metoprolol-mepha 200 mg depotabs

mepha pharma ag - metoprololi succinas - depotabs - metoprololi tartras 200 mg corresp. metoprololi succinas 190 mg, sacchari sphaerae corresp. saccharum 14.72 mg et maydis amylum, macrogolum 6000, polyacrylatis dispersio 30 per centum, talcum, povidonum, cellulosum microcristallinum, magnesii stearas, silica colloidalis anhydrica, Überzug: hypromellosum, talcum, macrogolum 6000, e 171, pro compresso obducto. - les bêta-bloquants - synthetika

Fluvastatin-Mepha 80 retard Depotabs Uswisi - Kifaransa - Swissmedic (Swiss Agency for Therapeutic Products)

fluvastatin-mepha 80 retard depotabs

mepha pharma ag - fluvastatinum - depotabs - fluvastatinum 80 mg ut fluvastatinum natricum 84.2 mg, carrageenanum, magnesii stearas, Überzug: hydroxypropylcellulosum, hypromellosum, macrogolum 8000, e 171, e 172 (flavum), e 172 (rubrum), pro compresso obducto, natrium 4.46 mg. - réduction de la serumcholesterinkonzentration, primaire dyslipidémie mixte - synthetika

Desfesoterodin-Mepha retard 3.5 mg Depotabs Uswisi - Kifaransa - Swissmedic (Swiss Agency for Therapeutic Products)

desfesoterodin-mepha retard 3.5 mg depotabs

mepha pharma ag - desfesoterodinum - depotabs - desfesoterodini succinas 3,5 mg corresp. desfesoterodinum 2,6 mg, color.: e 132, excipiens pro compresso obducto. - traitement de la vessie hyperactive - synthetika

Desfesoterodin-Mepha retard 7 mg Depotabs Uswisi - Kifaransa - Swissmedic (Swiss Agency for Therapeutic Products)

desfesoterodin-mepha retard 7 mg depotabs

mepha pharma ag - desfesoterodinum - depotabs - desfesoterodini succinas 7 mg corresp. desfesoterodinum 5.2 mg, color.: e 132, excipiens pro compresso obducto. - traitement de la vessie hyperactive - synthetika

Bydureon BCise 2 mg Depot-lnjektionssuspension in einem Autoinjektor Uswisi - Kifaransa - Swissmedic (Swiss Agency for Therapeutic Products)

bydureon bcise 2 mg depot-lnjektionssuspension in einem autoinjektor

astrazeneca ag - exenatidum - depot-lnjektionssuspension in einem autoinjektor - exenatidum 2 mg, saccharum, poly(lactidum-co-glycolidum) 50/50 (0.40 - 0.49 dl/g), triglycerida media, ad suspensionem pro dosi. - antidiabetikum - synthetika

Pentasa 500 mg Depot-Tabletten Uswisi - Kifaransa - Swissmedic (Swiss Agency for Therapeutic Products)

pentasa 500 mg depot-tabletten

ferring ag - mesalazinum - depot-tabletten - mesalazinum 500 mg, povidonum, ethylcellulosum, magnésium stearas, talc, cellulosum microcristallinum, pro compresso. - la colite ulcéreuse - synthetika